Document Detail


Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.
MedLine Citation:
PMID:  1887483     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques, were randomly assigned to treatment with either praziquantel 50 mg/kg/d for 15 d or albendazole 15 mg/kg/d for 30 d. All patients were treated in addition with steroids for 45 d. Follow-up was for 90 d for response to treatment and at least 1 year for recurrence. Although similar numbers of patients showed no improvement in neuroimaging criteria at 3 months, the response to albendazole was more pronounced with larger numbers showing marked improvement or disappearance of lesions. Resolution of the presenting neurological signs and symptoms was also more frequent in the albendazole group. Electroencephalographic changes also became normal. The use of steroid cover eliminated the headache frequently present during the first few days of treatment and permitted severe cases to be treated. Both albendazole and praziquantel appeared to be effective at the doses used, with albendazole showing a slightly better overall response.
Authors:
M Cruz; I Cruz; J Horton
Related Documents :
8315953 - A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.
18789123 - A case report of successful treatment with immunoadsorption onto protein a in mixed con...
10631383 - Additive triple dmard combination therapy of a low dose of sulfhydryl compounds, sulfas...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Transactions of the Royal Society of Tropical Medicine and Hygiene     Volume:  85     ISSN:  0035-9203     ISO Abbreviation:  Trans. R. Soc. Trop. Med. Hyg.     Publication Date:    1991 Mar-Apr
Date Detail:
Created Date:  1991-10-07     Completed Date:  1991-10-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7506129     Medline TA:  Trans R Soc Trop Med Hyg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  244-7     Citation Subset:  IM    
Affiliation:
Center for Research and Training in Neurosciences, Ecuadorean Academy of Neurosciences, Quito.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Albendazole / therapeutic use*
Animals
Brain Diseases / drug therapy*
Cysticercosis / complications,  drug therapy*,  radiography
Cysticercus / isolation & purification
Humans
Praziquantel / therapeutic use*
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
54965-21-8/Albendazole; 55268-74-1/Praziquantel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detection of antibodies against Echinococcus granulosus major antigens and their subunits by immunob...
Next Document:  The significance of low density microfilaraemia in the transmission of Wuchereria bancrofti by Culex...